Fundraising FoxLomond Therapeutics Holdings
Dover, US · Founded 2021 · Delaware corporation
Find your way into Lomond Therapeutics Holdings
Sign up to see every warm intro you have to Lomond Therapeutics Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lomond Therapeutics Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
ID
Iain DukesExecutive
NS
Nikolay SavchukExecutive
Board
CG
Carl GordonBoard director
ER
Eddie RodriguezBoard director
Reported raises · per SEC filings
Form D private placements$53.9M disclosed across 1 round · 2024
▶$53.9MraisedFeb 2025 · 28 investors · PharmaceuticalsRule 506(b)
▶$53.9MraisedFeb 2025 · 28 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Carl GordonDirector
- Iain DukesExecutive Officer, Director
- Eddie RodriguezDirector
- Nikolay SavchukExecutive Officer, Director
- Offering amount
- $63.9M
- Amount sold
- $53.9M
- Sales commissions
- $3.1M
- Placement agents
- Wedbush & Co., LLC, Raymond James & Associates, Inc.
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lomond Therapeutics Holdings raised?
- Lomond Therapeutics Holdings has disclosed $53.9M raised across 1 round.
- Where is Lomond Therapeutics Holdings headquartered?
- Lomond Therapeutics Holdings is headquartered in Dover, US.